Comparison of Laboratory Costs of Rapid Molecular Tests and Conventional Diagnostics for Detection of Tuberculosis and Drug-Resistant Tuberculosis in South Africa

BMC Infectious Diseases - United Kingdom
doi 10.1186/1471-2334-13-352
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cost Analysis of Rapid Diagnostics for Drug-Resistant Tuberculosis

BMC Infectious Diseases
Infectious Diseases
2018English

Extensively Drug-Resistant Tuberculosis in South Africa

The Lancet
Medicine
2010English

Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis

South African Respiratory Journal
2015English

Rapid Molecular Screening for Multidrug-Resistant Tuberculosis in a High-Volume Public Health Laboratory in South Africa

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2008English

Pre-Detection History of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Emergence and Spread of Extensively and Totally Drug-Resistant Tuberculosis, South Africa

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2013English

Evaluation of Nitrate Reductase Assay for Rapid Detection of Drug Resistant Tuberculosis

Journal of Health and Allied Sciences
2019English

Cost Outcome Analysis of Decentralized Care for Drug-Resistant Tuberculosis in Johannesburg, South Africa

PLoS ONE
Multidisciplinary
2019English

Cost-Effectiveness Comparison of Genechip and Conventional Drug Susceptibility Test for Detecting Multidrug-Resistant Tuberculosis in China

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy